Cargando…

Impact of Cancer Cachexia on Hospitalization-associated Physical Inactivity in Elderly Patients with Advanced Non-small-cell Lung Cancer

OBJECTIVE: New or worsening disability can develop in elderly patients in just 1 week of hospitalization for acute illness. Elderly patients with cancer, particularly those with cancer cachexia, are vulnerable to disability. This study aimed to explore the impact of hospitalization and cachexia on p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morikawa, Ayumu, Naito, Tateaki, Sugiyama, Miwa, Okayama, Taro, Aoyama, Takashi, Tanuma, Akira, Omae, Katsuhiro, Takahashi, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103202/ https://www.ncbi.nlm.nih.gov/pubmed/30271819 http://dx.doi.org/10.4103/apjon.apjon_20_18

Ejemplares similares

Impact of Physical Inactivity on the Risk of Disability and Hospitalization in Older Patients with Advanced Lung Cancer
por: Yonenaga, Yusuke, et al.
Publicado: (2021)

Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program
por: Mouri, Takako, et al.
Publicado: (2018)

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study
por: Naito, Tateaki, et al.
Publicado: (2017)

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer
por: Naito, Tateaki, et al.
Publicado: (2018)

Days Spent at Home near the End of Life in Japanese Elderly Patients with Lung Cancer: Post hoc Analysis of A Prospective Study
por: Notsu, Mikako, et al.
Publicado: (2021)

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer
por: Naito, Tateaki, et al.
Publicado: (2017)

A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol
por: Miura, Satoru, et al.
Publicado: (2019)

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
por: Naito, Tateaki
Publicado: (2019)

Nursing Management of Cancer Cachexia: A New Frontier
por: Naito, Tateaki
Publicado: (2021)

Challenges in enhancing physical performance in thoracic cancer cachexia
por: Naito, Tateaki
Publicado: (2021)

Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review
por: Naito, Tateaki
Publicado: (2019)

Barriers in Nursing Practice in Cancer Cachexia: A Scoping Review
por: Sato, Rika, et al.
Publicado: (2021)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
por: Miyawaki, Taichi, et al.
Publicado: (2020)

Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer
por: Miyawaki, Taichi, et al.
Publicado: (2022)

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
por: Takayama, Koichi, et al.
Publicado: (2022)

Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
por: Mamesaya, Nobuaki, et al.
Publicado: (2018)

Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2017)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
por: Hamauchi, Satoshi, et al.
Publicado: (2019)

Tracheal granuloma 7 years after extubation
por: Nakashima, Kazuhisa, et al.
Publicado: (2017)

Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer
por: Hayashi, Nakamasa, et al.
Publicado: (2017)

Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer
por: Harada, Hideyuki, et al.
Publicado: (2016)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index
por: Naito, Tateaki, et al.
Publicado: (2022)

ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
por: Mamesaya, Nobuaki, et al.
Publicado: (2017)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure
por: Kawamura, Takahisa, et al.
Publicado: (2016)

Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
por: Kawamura, Takahisa, et al.
Publicado: (2019)

Cancer cachexia.
por: Tisdale, M. J.
Publicado: (1991)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

Cancer cachexia
por: Dhanapal, Raghu, et al.
Publicado: (2011)

The Cachexia of Cancer
por: Williams, W. Roger
Publicado: (1897)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status
por: Mamesaya, Nobuaki, et al.
Publicado: (2023)

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
por: Kasahara, Norimitsu, et al.
Publicado: (2015)

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients
por: Ko, Ryo, et al.
Publicado: (2016)

Cancer Cachexia: Its Mechanism and Clinical Significance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The Adipokines in Cancer Cachexia
por: Mannelli, Michele, et al.
Publicado: (2020)

The Microbiota and Cancer Cachexia
por: Herremans, Kelly M., et al.
Publicado: (2019)

The effects of advanced age and serum α(1)‐acid glycoprotein on docetaxel unbound exposure and dose‐limiting toxicity in cancer patients
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rj16d4bo894v3l95ag97fv8r4j